Front Page
 

Blue Cross Medicare AdvantageSM wellness benefits
Researchers discover mutated gene that prevents diabetes
Medical ID bracelets can save your life
Get preferred pricing at these pharmacies
Save with generic drugs
Get a free workout booklet
Blue365 deal: Walkadoo
 

Fight diabetes with good nutrition
Tips for taking your medicine right
6 paths to a happier life
Get moving for better health
 
Beware of food-drug interactions
Antioxidants for good health
Protect your eyes from the sun
 
Is it more than a senior moment?
Tips for bolstering your memory
How to get more for your vacation bucks
Readers' stories of retiring and finding themselves anew
Drug companies collaborate on research
China's Terra Cotta Warriors come to Indianapolis
'LifeTimes' wins design award
Learn about Hope Paige, maker of fashionable medical ID bracelets
Learn about HealthWays, creator of the Walkadoo social walking program
BCBSOK social responsibility report
BCBSOK Alzheimer's grant
Your letters to "LifeTimes"
 
 
Play our 'Mystery Game'
Crossword puzzle
Sudoku puzzle
Word search puzzle
 
 
Medicare Basics
Recent News
Current Issue
Previous Issues
About LifeTimes Newsletter
Sign up for LifeTimes email updates
 


  facebook twitter youtube
  Learn more


 
Share |
Feature Stories

One doctor on turning 65: Rejoice! (And use screenings wisely)

Hadler Nortin

Nortin M. Hadler, M.D., professor of medicine at the University of North Carolina, believes older folks are "medicalized" – his term for "reframing ordinary life predicaments so they're viewed as diseases." His 2011 book, "Rethinking Aging: Growing Old and Living Well in an Overtreated Society," contends those 65-plus often get unneeded drugs, tests, treatments, and diagnoses.

"Doctors have long taken Hippocrates' 'do no harm' to heart, but in the 21st century we have the science to take his 'do good' to heart as well," says Hadler. "Treatments, procedures, and medicines must really work; they must be prescribed for 'important' diseases, and we must know we can achieve meaningful outcomes. If not, we really achieve very little."

One disease Hadler finds "unimportant" is prostate cancer. "For those few who actually get the worst forms, prostate cancer is very important. But we cannot identify the few among the many men whose cancer is not lethal – that's most men who will die with prostate cancer, but very few from it. They usually die from something else, typically heart disease." So though many men may be diagnosed with prostate cancer, few would have actually died from it if its natural course went untreated.

Hadler cites two large 2009 long-term randomized, controlled trials: the PLCO in America (76,693 men) and the ERSPC in Europe (162,387 men). The studies looked at the effect of cancer screening on mortality. Hadler's conclusion: "Screening 1,400 men for nine years would cause you to treat 48 more men, but avert prostate cancer death in one. That's a lot of over-diagnosis and over-treatment."

Other prostate cancer screening views

There are pros and cons to prostate cancer screening, and experts do not all agree on the best approach. In May 2012, the U.S. Preventive Services Task Force (USPSTF) said it "recommends against prostate-specific antigen (PSA)-based screening for prostate cancer. The USPSTF concludes that there is moderate certainty that the benefits of PSA-based screening for prostate cancer do not outweigh the harms." (Source: http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatefinalrs.htm)

By contrast, the American Cancer Society recommends that, "Men who have at least a 10-year life expectancy should have an opportunity to make an informed decision with their health care provider about whether to be screened for prostate cancer, after receiving information about the potential benefits, risks, and uncertainties associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision-making process." (Source: http://onlinelibrary.wiley.com/doi/10.3322/caac.20143/pdf)

Hadler's older-age prescription

"I wrote 'Rethinking Aging' (UNC Press, Chapel Hill, 2011) to help signal a change in the parlance of time from 'my time is limited' to 'my time is valuable, too valuable not to capture every moment I can.' Whether robust or frail, make time slow down."

Hadler says, at 65, rejoice for having lived this long and for the fact that you are in the first generation in history that can rationally ask how to productively spend the next 15-20 years. "Aging isn't a disease. Frail elderly persons aren't a burden. Marginalizing this time of life deprives our communities of lifeblood and denies the aged the sense of vitality that is the privilege of longevity in the 21st century. Older people must think of themselves as, and be treated as, people with a future, not only a past."